The FDA has released its recommendations—based on a report by the WHO—for the vaccine components of next year's trivalent and quadrivalent influenza vaccines.
The FDA has approved Zarxio (filgrastim-sndz), the first biosimilar product to be released in the United States, for indications including certain patients with cancer, leukemia, and neutropenia.
Jesse G. O’Shea, MS (MD Candidate); Kenneth Brummel-Smith, MD; Suzanne Baker, MA; LaVon Edgerton, BA
Jesse G. O’Shea, MS (MD Candidate); Kenneth Brummel-Smith, MD; Suzanne Baker, MA; LaVon...
In this commentary, the authors describe how they assessed recent Medicare access trends at a local level, specifically in a midsize metropolitan city.
Making improvements in HIV diagnosis and retention in care is as important as reducing high-risk sexual and drug use behaviors in terms of cutting the number of HIV transmissions in the United States,...